Why Exelixis Inc. Stock Plunged

Fool.com Headlines http://ift.tt/1oAJvDr Exelixis' stock is among today's biggest losers after its late-stage prostate cancer trial failed to meet its primary endpoint. See what shareholders should be focused on going forward.